期刊文献+

食管癌组织中IDO1的表达及犬尿酸对间皮素CAR-T细胞功能的影响 被引量:3

Expression of IDO1 and effects of kynurenine on the function of mesothelin-CAR-T cells
下载PDF
导出
摘要 目的:探讨食管癌组织中吲哚加双氧酶1(IDO1)的表达,及其代谢产物犬尿酸对间皮素嵌合抗原受体T细胞(CAR-T)功能的影响。方法:利用癌症基因组图谱(TCGA)数据库中数据分析食管癌组织中IDO1的表达对患者生存的影响;采用密度梯度离心法获得健康供者外周血单个核细胞,并用细胞免疫磁珠分选出CD8+T细胞;采用病毒感染的方法制备间皮素CAR-T细胞,用200μmol/L犬尿酸处理48 h后,采用流式细胞术检测细胞表面标志物的表达和细胞内因子分泌的水平,检测其对KYSE510细胞的杀伤能力。以未用犬尿酸处理的间皮素CAR-T细胞作对照。结果:高表达IDO1的食管癌患者预后较差。与对照组相比,犬尿酸处理组间皮素CAR-T细胞表面抑制性分子PD-1表达上调(P <0. 05),而激活性分子CD28表达下降(P <0. 05),效应因子IFN-γ和IL-2分泌减少(P <0. 05);与KYSE510细胞共孵育后,间皮素CAR-T细胞CD107a表达降低,杀伤能力下降(P <0. 05)。结论:犬尿酸可以抑制间皮素CAR-T细胞的功能。 Aim:To investigate the expression of IDO1 and the effects of IDO1 metabolite kynurenine on the function of mesothelin-CAR-T cells.Methods:The expression of IDO1 in esophagus cancer and its effects on patients′survival were analyzed using TCGA database.The peripheral blood mononuclear cells of healthy donors were isolated by density gradient centrifugation,and then the CD8^+T cells were sorted using immunomagnetic beads.Mesothelin-CAR-T cells were prepared by virus infection.After being treated by 200μmol/L kynurenine for 48 hours,the surface markers and cytokine production of mesothelin-CAR-T cells were determined by flow cytometry.Mesothelin-CAR-T cells were co-incubated with esophagus cancer KYSE510 cells,and flow cytometry was used to detect the effects of kynurenine on the killing function of mesothelin-CAR-T cells.The cells not treated were the control.Results:Esophagus cancer patients with overexpressed IDO1 had a poor prognosis.Compared with control group,kynurenine could induce the up-regulation of the immune checkpoint PD-1 on mesothelin-CAR-T cells(P<0.05),and down-regulation expression of activated marker CD28(P<0.05).Moreover,kynurenine could also inhibit the cytokines IFN-γand IL-2 secretion of mesothelin-CAR-T cells(P<0.05).After co-incubation with tumor cells,kynurenine inhibited the killing function of mesothelin-CAR-T cells(P<0.05).Conclusion:Kynurenine can inhibit the function of mesothelin-CAR-T cells.
作者 刘裕琳 张震 曹玲 申春一 张毅 LIU Yulin;ZHANG Zhen;CAO Ling;SHEN Chunyi;ZHANG Yi(Biotherapy Center,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052;Cancer Center,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052;Henan Key Laboratory for Tumor Immunotherapy and Biotherapy,Zhengzhou 450052;Department of Immunology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001;School of Life Sciences,Zhengzhou University,Zhengzhou 450001)
出处 《郑州大学学报(医学版)》 CAS 北大核心 2019年第3期344-348,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目(81771781 U1804281 81802857) 国家重点研发计划重点专项基金资助项目(2018YFC1313400) 河南省重大科技专项基金资助项目(161100311000)
关键词 吲哚加双氧酶1 犬尿酸 间皮素CAR-T细胞 食管癌 免疫治疗 IDO1 kynurenine mesothelin-CAR-T cell esophagus cancer immunotherapy
  • 相关文献

参考文献5

二级参考文献88

  • 1Michael R. Verneris,Martin Kornacker,Volker Mail?nder,Robert S. Negrin.Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis[J]. Cancer Immunology, Immunotherapy . 2000 (6)
  • 2Richard L. Kradin,Lenora A. Boyle,Frederic I. Preffer,Ronald J. Callahan,Martha Barlai-Kovach,H. William Strauss,Steven Dubinett,James T. Kurnick.Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer[J]. Cancer Immunology Immunotherapy . 1987 (1)
  • 3Frankel TL,Burns WR,Peng PD,et al.Both CD4and CD8T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosi-nase. J Immunol . 2010
  • 4Koya RC,Mok S,Comin-Anduix B,et al.Kinetic phases of distribution and tumor targeting by T cell receptor engi-neered lymphocytes inducing robust antitumor responses. Proceedings of the National Academy of Sciences of the United States of America . 2010
  • 5Duval L,Schmidt H,Kaltoft K,et al.Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2restricted MART-1T-cell receptor:a phaseⅠtrial in meta-static melanoma. Clinical Cancer Research . 2006
  • 6Warren EH,Fujii N,Akatsuka Y,et al.Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantationwith T cells specific for minor histocompatibility antigens. Blood . 2010
  • 7Khammari A,Labarrire N,Vignard V,et al.Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones. Journal of Investigative Dermatology . 2009
  • 8Casalegno-Garduo R,Schmitt A,Yao J,et al.Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunology Immunotherapy . 2010
  • 9Geldmacher A,Freier A,Losch FO,et al.Therapeutic vac-cination for cancer immunotherapy:antigen selection and clinical responses. Hum Vaccin . 2011
  • 10Vergati M,Intrivici C,Huen NY,et al.Strategies for cancer vaccine development. Journal of Biomedicine and Biotechnology . 2010

共引文献42

同被引文献24

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部